ORO Health

Founded in 2018 in Montreal, Canada, ORO Health delivers telemedicine solutions, effectively addressing healthcare accessibility. The co-founders, Emilie Bourgeault, Jean-Philippe Doré, and Marc-Andre Faad, have a background in healthcare technology.Oro Health specializes in asynchronous telemedicine solutions tailored for dermatologists and specialists seeking to enhance patient care while optimizing their workflow. The core product offering is the Oro DermSmart AI, an integrated diagnostic and treatment recommendation tool specifically designed for minor skin conditions. This artificial intelligence-driven platform aids in pre-triaging patients, allowing dermatologists to focus on more complex cases while providing patients with timely treatment recommendations without necessitating an in-person consultation. Oro Health's solutions are primarily directed at healthcare professionals in Canada, addressing the critical need for efficient dermatological care, particularly in underserved areas outside major urban centers.Oro Health's revenue model is structured around subscription services for healthcare professionals who integrate their telemedicine solutions into their practices. Dermatologists and specialists pay for access to the Oro DermSmart AI platform, which streamlines patient interactions and simplifies administrative tasks. Client transactions typically involve subscription fees that cover software usage, maintenance, and ongoing updates to the AI technology. The company focuses on building partnerships with medical clinics and independent practitioners, facilitating direct-to-consumer accessibility for patients seeking dermatological advice and treatment recommendations., and TGIC2. ORO Health plans to introduce new features and enhancements to the Oro DermSmart AI platform while expanding its reach to additional markets in Canada, specifically targeting underserved regions by the end of 2023.

1. Seed

   Aug 11, 2021

   Amount

   Undisclosed

   Investors

   Locked